ArticlePaediatric drugs2018

Correction to: Palivizumab Prophylaxis Against Respiratory Syncytial Virus Infection in Children with Immunocompromised Conditions or Down Syndrome: A Multicenter, Post-Marketing Surveillance in Japan.

Tomoko Kashiwagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.